Qing HE, Zhaoyang YE, Yan ZHOU, Wen-song TAN

Comparative study of mesenchymal stem cells from rat bone marrow and adipose tissue

Several therapeutic products based on mesenchymal stem cells (MSCs) have been translated into clinical applications. MSCs should undergo in vitro culture before a sufficient quantity can be achieved. Hence, both expansion kinetics and the biological characteristics of derived cells from primary culture are pertinent to their applications. In the present study, MSCs were isolated from rat bone marrow and adipose tissue (designated as bMSCs and aMSCs, respectively) and cells were comparatively analyzed regarding cell morphology, proliferation, colony formation, differentiation potential, and immunophenotype following the long-term subculture. No apparent differences could be noticed concerning the morphology between bMSCs and aMSCs. The long-term subculture made both types of cells smaller, weakened their colony-forming ability, and stimulated the proliferation rate. However, bMSCs demonstrated better proliferation and colony-forming ability than aMSCs. No significant difference was observed about the expression of some immunophenotypes (i.e. CD29+/CD90+/CD34-/CD45-) regardless of cell types or population doublings. Notably, bMSCs, but not aMSCs, maintained the differentiation potential well after the long-term subculture. The present study demonstrates that MSCs derived from different tissues can be well expanded for the long term, although cells display gradually declined self-renewal and differentiation potentials to different extents depending on the tissue origins.

Keywords:

Adipose tissue bone marrow, comparative analysis, long-term culture, mesenchymal stem cells,

PDF

___

Anderson P, Cobo M, Martín F (2003). CD105 (endoglin)- negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS One 8: e76979.
Bara JJ, Richards RG, Alini M, Stoddart MJ (2014). Concise review: bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells 32: 1713-1723.
Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R (2003). Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287: 98-105.
Bortolotti F, Ukovich L, Razban V, Martinelli V, Ruozi G, Pelos B, Dore F, Giacca M, Zacchigna S (2015). In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure. Stem Cell Rep 4: 332-339.
Çelebi B, Elçin AE, Elçin YM (2009). Proteome analysis of rat bone marrow mesenchymal stem cell differentiation. J Proteome Res 8: 5217-5227.
Çelebi B, Elçin YM (2009). Proteome analysis of rat bone marrow mesenchymal stem cell subcultures. J Proteome Res 8: 2164- 2172.
Chen JY, Mou XZ, Du XC, Xiang C (2015). Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins. Asian Pac J Trop Med 8: 725- 731.
Colter DC, Class R, Digirolamo CM, Prockop DJ (2000). Rapid expansion of recycling stem cells in cultures of plastic- adherent cells from human bone marrow. P Natl Acad Sci USA 97: 3213-3218.
Deasy BM, Gharaibeh BM, Pollett JB, Jones MM, Lucas MA, Kanda Y, Huard J (2005). Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell 16: 3323-3333.
Dijk CGMV, Nieuweboer FE, Jia YP, Yan JX, Burgisser P, Mulligen EV, Azzouzi HE, Duncker DJ, Verhaar MC, Cheng C (2015). The complex mural cell: pericyte function in health and disease. Int J Cardiol 190: 75-89.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2009). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
Dos Santos F, Andrade PZ, Da SC, Cabral J (2013). Bioreactor design for clinical-grade expansion of stem cells. Biotechnol J 8: 644- 654. Dos Santos F, Campbell A, Fernandes-Platzgummer A, Andrade PZ, Gimble JM, Wen Y, Boucher S, Vemuri MC, Silva CLD, Cabral JMS (2014). A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells. Biotechnol Bioeng 111: 1116-1127.
Estes BT, Diekman BO, Gimble JM, Guilak F (2010). Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 5: 1294-1311.
Fuchs E, Tumbar T, Guasch G (2004). Socializing with the neighbors: stem cells and their niche. Cell 116: 769-778.
Fukiage K, Aoyama T, Shibata KR, Otsuka S, Furu M, Kohno Y, Ito K, Jin Y, Fujita S, Fujibayashi S et al. (2008). Expression of vascular cell adhesion molecule-1 indicates the differentiation potential of human bone marrow stromal cells. Biochem Biophys Res Commun 365: 406-412.
Guneta V, Tan NS, Chan SKJ, Tanavde V, Lim TC, Wong TCM, Choong C (2016). Comparative study of adipose-derived stem cells and bone marrow-derived stem cells in similar microenvironmental conditions. Exp Cell Res 348: 155-164.
Gu Y, Li T, Ding Y, Sun L, Tu T, Zhu W, Hu JB, Sun XC (2016). Changes in mesenchymal stem cells following long-term culture in vitro. Mol Med Rep 13: 5207-5215.
Heathman TR, Glyn VA, Picken A, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ (2015). Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng 112: 1696- 1707.
Huang S, Xu L, Sun Y, Wu T, Wang K, Li G (2015). An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J Orthop Transl 3: 26-33.
Jiang T, Liu W, Lv X, Sun H, Zhang L, Liu Y, Zhang WJ, Cao YL, Zhou GD (2010). Potent in vitro chondrogenesis of CD105 enrich human adipose-derived stem cells. Biomaterials 31: 3564-3571.
Kanth KL, Sahitya S, Srinivas M, Sruthi KR (2015). Adipose tissue - adequate, accessible regenerative material. Int J Stem Cells 8: 121-127.
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294- 1301.
Lee TC, Lee TH, Huang YH, Chang NK, Lin YJ, Chien PW, Yang WH, Lin MH (2014). Comparison of surface markers between human and rabbit mesenchymal stem cells. PLoS One 9: e111390.
Li XY, Ding J, Zheng ZH, Li XY, Wu ZB, Zhu P (2012). Long-term culture in vitro impairs the immunosuppressive activity of, mesenchymal stem cells on T cells. Mol Med Rep 6: 1183-1189.
Lim J, Razi ZRM, Law J, Nawi AM, Idrus RBH, Min HN (2016). MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord. Cytotherapy 18: 1493-1502.
Marappagounder D, Somasundaram I, Janvikula RS, Dorairaj S (2012). Long-term culture optimization of human omentum fat-derived mesenchymal stem cells. Cell Biol Int 36: 1029- 1036.
Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F (2001). Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86: 1099- 1100.
Meirelles LS, Nardi NB (2003). Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Brit J Haematol 123: 702-711.
Mizukami A, Fernandes-Platzgummer A, Carmelo JG, Swiech K, Covas DT, Cabral JMS, Silva CLD (2016). Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells. Biotechnol J 11: 1048-1059.
Mohamadfauzi N, Ross PJ, Maga EA, Murray JD (2015). Impact of source tissue and ex vivo expansion on the characterization of goat mesenchymal stem cells. J Anim Sci Biotechno 6: 1-23.
Muraglia A, Cancedda R, Quarto R (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113: 1161-1166.
Nishigaki F, Ezoe S, Kitajima H, Hata K (2017). Human resource development contributes to the creation of outstanding regenerative medicine products. Regen Ther 7: 17-23.
Otte A, Bucan V, Reimers K, Hass R (2013). Mesenchymal stem cells maintain long-term in vitro stemness during explant culture. Tissue Eng Part C Methods 19: 937-948.
Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C (2008). Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem cells Dev 17: 761- 773.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
Ran B, Ran B, Sadan O, Ran B, Sadan O, Melamed E, Offen D (2009). Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains. Cytotherapy 11: 435-442.
Sugii S, Kida Y, Berggren WT, Evans RM (2011). Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 6: 346-358.
Sung JH, Yang HM, Park JB, Cho i GS, Joh JW, Kwon CH, Chun JM, Lee SK, Kim SJ (2008). Isolation and characterization of mouse mesenchymal stem cells. Transpl P 40: 2649-2654.
Tancharoen W, Aungsuchawan S, Pothacharoen P, Markmee R, Narakornsak S, Kieodee J, Boonma J, Tasuya W (2017). Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Acta Histochem 119: 113-121.
Wu X, Kang H, Liu X, Gao J, Zhao K, Ma Z (2016). Serum and xeno-free, chemically defined, no-plate-coating-based culture system for mesenchymal stromal cells from the umbilical cord. Cell Prolif 49: 579-588.